Neuroprotection and neurorepair
Tuesday, 09.10.2018 | 05:30 – 07:15 pm
| 5:30 – 5:45 pm |
Rebecca Sadler (Munich, Germany) |
The role of short-chain fatty acids in post- stroke regeneration. |
| 5:45 – 6:00 pm |
Liubov Gorbacheva (Moscow, Russia) |
Inhibition of nuclear factor-κB activation is the key event of anti-inflammatory and protective effects of activated protein C at mast cells and neurons |
| 6:00 – 6:15 pm |
Mary Lopez (Madison, USA) |
The microRNA miR-21 protects the brain from focal ischemic stroke as described by the Stroke Academic Industry Therapeutic Roundtable (STAIR) recommendations by inhibiting pro-inflammatory and pro-apoptotic pathways |
| 6:15 – 6:30 pm |
Jordi Pedragosa (Barcelona, Spain) |
Selective Ccr2 gene deletion in myeloid cells impairs spontaneous functional recovery following stroke in mice |
| 6:30 – 6:45 pm |
Arnold Szabo (Budapest, Hungary) |
Long-term organotypic culture of the adult human retina: A new reliable method for studying neuroprotection and neurorepair |
| 6:45 – 7:00 pm |
Mikko Airavaara (Helsinki, Finland) |
Post-stroke MANF administration facilitates functional recovery and brain repair |
| 7:00 – 7:15 pm |
Saema Ansar (Lund, Sweden) |
Combination treatment with U0126 and t-PA reduces adverse effect of delayed t-PA treatment after stroke |